IONIS PHARMACEUTICALS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Ionis Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q3 2024.
  • Ionis Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$140M, a 4.7% increase year-over-year.
  • Ionis Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$359M, a 12.4% increase year-over-year.
  • Ionis Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$366M, a 35.8% decline from 2022.
  • Ionis Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$270M, a 843% decline from 2021.
  • Ionis Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$28.6M, a 93.6% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$359M -$140M +$6.93M +4.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$366M -$66.3M +$19M +22.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$385M -$143M -$18.5M -14.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$366M -$9.26M +$43.2M +82.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 -$409M -$147M -$100M -214% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$309M -$85.3M +$19.8M +18.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$329M -$124M -$59.2M -90.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$270M -$52.4M -$277M -123% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $7.32M -$47M +$35.5M +43% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$28.2M -$105M -$24.3M -30% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$3.89M -$65.2M +$24.7M +27.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$28.6M $225M +$579M Oct 1, 2021 Dec 31, 2021 10-K 2022-02-25
Q3 2021 -$608M -$82.5M -$58M -237% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$550M -$80.9M -$55.2M -215% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$495M -$89.9M -$50.2M -127% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$444M -$355M -$539M -292% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-25
Q3 2020 $94.7M -$24.5M -$50.6M -194% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $145M -$25.6M -$24.8M -2826% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $170M -$39.6M -$124M -147% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $294M $184M -$136M -42.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-24
Q3 2019 $430M $26.2M +$30.7M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $399M -$876K +$39.5M +97.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $360M $84.4M +$85.9M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $274M $320M +$323M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$49.3M -$4.56M -$1.95M -74.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$47.3M -$40.4M -$37.3M -1208% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$10M -$1.42M -$10.4M -116% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 $346K -$2.92M -$28.8M -111% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 $29.1M -$2.61M -$9.96M -136% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 $39.1M -$3.09M +$53.8M +94.6% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$14.7M $8.96M +$71.9M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$86.6M $25.9M +$97.3M Oct 1, 2016 Dec 31, 2016 10-K 2017-03-01
Q3 2016 -$184M $7.35M +$43.1M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$227M -$56.9M -$92.5M -259% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$134M -$62.9M -$46.2M -276% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$88.3M -$71.4M -$102M -330% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-01
Q3 2015 $14.2M -$35.8M -$9.1M -34.1% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-01
Q2 2015 $23.3M $35.6M +$47.7M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-01
Q1 2015 -$24.4M -$16.7M +$14.6M +46.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-01
Q4 2014 -$39M $31.1M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-26
Q3 2014 -$26.7M Jul 1, 2014 Sep 30, 2014 10-K 2016-02-26
Q2 2014 -$12.1M Apr 1, 2014 Jun 30, 2014 10-K 2016-02-26
Q1 2014 -$31.3M Jan 1, 2014 Mar 31, 2014 10-K 2016-02-26
Q2 2011 -$64.3M -$17.9M +$7.27M +28.9% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-08
Q1 2011 -$71.6M -$20M -$10.3M -107% Jan 1, 2011 Mar 31, 2011 10-Q 2011-05-06
Q4 2010 -$61.3M -$14M Oct 1, 2010 Dec 31, 2010 10-K 2011-03-01
Q3 2010 -$12.5M Jul 1, 2010 Sep 30, 2010 10-Q 2010-11-05
Q2 2010 -$25.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 -$9.66M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.